175 related articles for article (PubMed ID: 33194623)
1. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma.
Huang W; Yan YG; Wang WJ; Ouyang ZH; Li XL; Zhang TL; Wang XB; Wang B; Lv GH; Li J; Zou MX
Front Oncol; 2020; 10():556902. PubMed ID: 33194623
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
[TBL] [Abstract][Full Text] [Related]
3. A four-factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma.
Zou MX; Pan Y; Huang W; Zhang TL; Escobar D; Wang XB; Jiang Y; She XL; Lv GH; Li J
Clin Transl Med; 2020 Jan; 10(1):224-237. PubMed ID: 32508056
[TBL] [Abstract][Full Text] [Related]
4. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
6. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions.
Liu T; You X; Sui J; Shen B; Zhang Y; Zhang XM; Yang S; Yao YZ; Yang F; Yin LH; Pu YP; Liang GY
J Cell Biochem; 2019 May; 120(5):7185-7198. PubMed ID: 30390338
[TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma.
Chen Y; Wang Z; Li H; Li Y
Front Cell Dev Biol; 2021; 9():661105. PubMed ID: 34336826
[TBL] [Abstract][Full Text] [Related]
9. A novel miRNA-based signature as predictive tool of survival outcome of colorectal cancer patients.
Zhao B; Wang W; Ye H; Wang J; Meng K; Yang T
Chem Biol Drug Des; 2023 Nov; 102(5):1024-1033. PubMed ID: 37532274
[TBL] [Abstract][Full Text] [Related]
10. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
[TBL] [Abstract][Full Text] [Related]
11. Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer.
Fu K; Li Y; Song J; Cai W; Wu W; Ye X; Xu J
Front Genet; 2021; 12():650102. PubMed ID: 33936173
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
13. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
[TBL] [Abstract][Full Text] [Related]
14. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
Lv Y; Duanmu J; Fu X; Li T; Jiang Q
PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
[TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.
Wang N; Guo H; Dong Z; Chen Q; Zhang X; Shen W; Bao Y; Wang X
Cancer Manag Res; 2018; 10():3463-3471. PubMed ID: 30254489
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
17. A 4-miRNA signature to predict survival in glioblastomas.
Hermansen SK; Sørensen MD; Hansen A; Knudsen S; Alvarado AG; Lathia JD; Kristensen BW
PLoS One; 2017; 12(11):e0188090. PubMed ID: 29136645
[TBL] [Abstract][Full Text] [Related]
18. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
Meng T; Wang Q; Yang Y; Ren Y; Shi Y
Front Genet; 2022; 13():825261. PubMed ID: 35495130
[No Abstract] [Full Text] [Related]
19. Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma.
Ji Y; Wang L; Chang G; Yan J; Dai L; Ji Z; Liu J; He M; Xu H; Zhang L
Biol Direct; 2023 Feb; 18(1):5. PubMed ID: 36829221
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling and bioinformatics analyses reveal the potential roles of microRNAs in chordoma.
Chen K; Chen H; Zhang K; Sun S; Mo J; Lu J; Qian Z; Yang H
Oncol Lett; 2017 Nov; 14(5):5533-5539. PubMed ID: 29113181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]